07:00 Mon 29 Jan 2018
Concepta PLC - Results of Chinese hospital evaluations of myLotus
("Concepta" or the "Company")
Results of hospital evaluations of myLotus product in
Over a 12 week period (August -
64 women participated in the LH** (ovulation) tests and 59 women in the hCG*** (pregnancy) tests.
The results of the hospital evaluations for ovulation testing showed 100% correlation between myLotus and laboratory blood tests. The evaluation also included a comparison with a leading home test. As myLotus also provides quantitative results, the evaluation showed that it is possible for women who commonly experience weaker positives to ascertain exactly when they are about to ovulate much more accurately in comparison to using the existing commercially available home tests.
The evaluations for pregnancy testing were equally impressive, with myLotus achieving a correlation of over 98% with blood tests.
"In many other markets, the route to market differs to that of
*All data is kept on file and published articles will be referenced on Concepta's website once approved for release.
Enquiries:
The Company
CEO
Tel: +44 (0) 1234 866601
Tel: +44 (0)20 368 3550
+44 (0) 20 7399 9400
Tel: +44 (0) 776 932 5254
About
myLotus is currently the only consumer product which allows both quantitative and qualitative measurements of a woman's personal LH** and hCG***hormone levels in a home test, facilitating higher conception rates and early diagnosis of issues with fertility hormones. The proposition of myLotus is to help women conceive naturally.
Concepta has made significant progress recently, establishing agreements with a number of distributors in
The Company is also well on its way to achieving CE-marking and commencing its direct-to-consumer launch in the
*Unexplained infertility refers to women that have been unable to conceive after 6 months of trying. This highly motivated target group of consumers won't typically be offered medical intervention until 12 months of unsuccessfully trying, with IVF not offered until two years. Research indicates couples start to take positive action ahead of this time and there is little medical support to help them do so.
** LH: Luteinising hormone is produced by the pituitary gland and is one of the main hormones that control the reproductive system.
*** hCG: Human chorionic gonadotropin is a hormone produced by the placenta after implantation and is an indicator of pregnancy.
About RNS Reach announcements
RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.
This information is provided by RNS
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE